| 摘要 |
PROBLEM TO BE SOLVED: To provide a compound for treating neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders. SOLUTION: The invention relates to a free form or a pharmaceutically permitted salt form of substituted aminoalkanephosphonic acid, ä[(7-nitro-2,3-dioxo-1,2,3,4-tetrahydro-quinoxalin-5-ylmethyl)-amino]-methyl}-phosphonic acid, (R)-N-(2,3-dioxo-7-nitro-1,2,3,4-tetrahydroquinoxalin-5-ylmethyl)-α-(ethylamino)-ethylphosphonic acid, or (S)-N-(7-bromo-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-ylmethyl)-α-aminoethylphosphonic acid, in treating neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders. COPYRIGHT: (C)2009,JPO&INPIT
|
